Australia Pranlukast Market Size & Outlook, 2026-2034


Australia Pranlukast Market Insights

  • Reed Intelligence analysis indicates that the Australia Pranlukast Market size, valued at USD 6.44 Billion in 2025, is expected to expand to USD 14.32 Billion by 2034.
  • The Australia market is forecasted to expand at a CAGR of 9.24% spanning 2026–2034.
  • Tablets held the leading position among Formulation Type segments in 2025, based on market size.
  • Capsules is projected to post the fastest growth rate, sustaining its position as the most attractive Formulation Type segment during the forecast horizon.

Other Key Findings


  • In 2025, Australia represented 0.87% of the overall global Pranlukast Market size.
  • United States is projected to lead the global Pranlukast Market size by 2034.
  • Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2034.
  • Taiwan is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 15.13 Billion by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 6.44 Billion
Market Size In 2034 USD 14.32 Billion
Largest segment Tablets
Units Revenue in USD Billion
CAGR 9.24% (2026-2034)
Segmnetation Covered
Formulation Type
  1. Tablets
  2. Capsules
  3. Oral Suspensions
  4. Others
Application
  1. Asthma Treatment
  2. Allergic Rhinitis Treatment
  3. Bronchitis Management
  4. Others
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Drug Stores
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends